Results show that RHOA and CDC42 expression was significantly decreased (p = 0.0036, p = 0.0044, respectively) in COVID-19 compared with non-COVID-19 patients (Figure 2A.I,B.I). This evidence concerns the gene CDC42 and COVID-19.